Studies have observed that QE showed hepatoprotective and antifibrotic effects in animal models of liver fibrosis, which may be involved in modulating the HMGB1-TLR2/4-NF-κB signaling pathways (Li et al., 2016). Here, NFKB1 is linked to Hepatic fibrosis.